This report focuses on the global Nucleic Acid-based Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nucleic Acid-based Therapeutics development in United States, Europe and China. Gene therapy is a technique for correcting defective genes responsible for disease development. Nucleic acid-based molecules (deoxyribonucleic acid, complementary deoxyribonucleic acid, complete genes, ribonucleic acid, and oligonucleotides) are utilized as research tools within the broad borders of gene therapy and the emerging field of molecular medicine. Although most of the nucleic acid-based drugs are in early stages of clinical trials, these classes of compounds have emerged in recent years to yield extremely promising candidates for drug therapy to a wide range of diseases, including cancer, infectious diseases, diabetes, cardiovascular, inflammatory, and neurodegenerative diseases, cystic fibrosis, hemophilia, and other genetic disorders. In 2017, the global Nucleic Acid-based Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025. The key players covered in this study Wave Life Sciences Imugene Caperna Phylogica Protagonist Therapeutics Benitec Biopharma EGEN BioMedica Transgene Copernicus Therapeutics Market segment by Type, the product can be split into Anti-Sense And Anti-Gene Short Inhibitory Sequences Gene Transfer Therapy Nucleoside Analogs Ribozymes Aptamers Market segment by Application, split into Monogenetic Disorders Multi-Genetic Disorders Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Nucleic Acid-based Therapeutics status, future forecast, growth opportunity, key market and key players. To present the Nucleic Acid-based Therapeutics development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Nucleic Acid-based Therapeutics are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Nucleic Acid-based Therapeutics Market Size Growth Rate by Type (2013-2025) 1.4.2 Anti-Sense And Anti-Gene 1.4.3 Short Inhibitory Sequences 1.4.4 Gene Transfer Therapy 1.4.5 Nucleoside Analogs
